Buzz Stocks: Anavex Life Sciences Corp., Canadian Solar Inc., and Tesla Motors Inc

Today's stocks to watch include Anavex Life Sciences Corp. (AVXL), Canadian Solar Inc. (CSIQ), and Tesla Motors Inc (TSLA)

Mar 10, 2016 at 9:15 AM

U.S. stocks are set to open higher, following the European Central Bank's (ECB) stimulus decision. Among equities in focus are drugmaker Anavex Life Sciences Corp. (NASDAQ:AVXL), alternative energy stock Canadian Solar Inc. (NASDAQ:CSIQ), and Model S designer Tesla Motors Inc (NASDAQ:TSLA).

AVXL is poised to pop 8.7% at the open, after the drugmaker extended its trial for an Alzheimer's treatment by two years. The shares could certainly use the boost, considering they've lost over 65% since their four-year high of $14.84 in early November, settling yesterday at $5.16. Traders at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have been betting bullishly on Anavex Life Sciences Corp. in recent weeks -- buying to open 4.42 calls for every put.

On the flip side, CSIQ is pointed 6.3% lower pre-market, as traders react negatively to the solar company's disappointing revenue guidance -- which is overshadowing its better-than-expected fourth-quarter earnings. Ahead of the earnings report, option traders took a glass-half-full approach. Canadian Solar Inc.'s 10-day ISE/CBOE/PHLX call/put volume ratio of 2.81 ranks near the top quartile of its annual range. Possibly even more optimistic than option traders have been analysts, as all eight brokerage firms tracking the stock rate it a "strong buy." Technically speaking, however, CSIQ hasn't been much to write home about, losing nearly one-quarter of its value year-to-date at $21.76.

The Virginia Automobile Dealers Association (VADA) has filed suit against TSLA, attempting to block the automaker from opening a second dealership in the state. However, the stock is seemingly shrugging off the news, up nearly 2% ahead of the bell. In fact, Tesla Motors Inc has been on a tear since its two-year low of $141.05 in early February, soaring 48% to trade at $208.72. As such, bearish option traders -- and infamous short seller Citron Research -- may be starting to get nervous. During the past two weeks at the ISE, CBOE, and PHLX, TSLA has amassed a put/call volume ratio of 1.16, which sits just 6 percentage points from an annual high.

Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Follow @Schaeffers

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade. Professional traders have rushed into the market and are making a mint. Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.